Expensive UK stocks prompt Evenlode Income manager to seek opportunities abroad.
Manager eyes exceptionally cheap companies as economy has ‘started to reverse’.
Polar Capital manager says investing in biotech is not in keeping with trust’s low-risk mandate.
Henderson manager has added between 4-5% to equities across ‘pretty much all funds’.
Scottish Widows Investment Partnership (Swip) brand set to disappear as fund name changes planned for next week; subsequent mergers likely.
Group’s head of discretionary sales has left the company.
Analysis & Opinion
When it comes to polling day, will our ethics really hold up? Or will we vote for profit in our conscience investment decisions, asks Jon Cudby
How manager Tim Dieppe runs this global growth portfolio with a sustainable focus.
Green funds no longer a niche play as climate change threatens.
Accessing alpha may be challenging for some investors.
More on Equities
Week in Brief: Sesame will not follow Ashley Law, GARs in TCF spotlight and Mas’ complex relationship with advisers.
Clients are upping risk after a long period of gains in markets meaning advice has a chance to prove its worth.
Nov 18, 2014
Markets will become a ‘bit jittery’ as the election approaches, Octopus manager says.
Alternative Investments| Nov 18, 2014
Large-cap biotech firms are set to do well in 2015, with a raft of potentially lucrative new drugs.
Emerging Markets| Nov 18, 2014
Shanghai Connect initiative provides ‘huge investment opportunity’ for investors.
European| Nov 17, 2014
Giles Worthington to manage the Smith & Williamson European Growth Trust as former manager Michael Pascall leaves.